Trospium / Xanomeline and Lemborexant: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Lemborexant
Trospium / Xanomeline
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Let's talk about taking Dayvigo (lemborexant), your sleep medicine, together with Cobenfy, which contains xanomeline. Xanomeline can briefly slow down an enzyme in your gut called CYP3A4, the same enzyme that helps break down lemborexant. When that enzyme is slowed, a little more lemborexant may get into your body than usual.
In plain terms, that could make lemborexant's effects stronger, so you might feel more drowsy, groggy the next morning, or dizzy. This is a theoretical concern, meaning it hasn't been firmly proven in studies. The good news is your care team can manage it easily by watching how you feel and adjusting things if needed. Keep taking both as prescribed and let them know if you feel extra sleepy.
Mechanism: Xanomeline (in Cobenfy) transiently inhibits intestinal CYP3A4 without meaningful systemic inhibition. Lemborexant is a sensitive oral CYP3A4 substrate, so co-administration may increase its exposure (AUC/Cmax).
Direction: Increased lemborexant exposure, raising the frequency/severity of dose-related adverse effects (somnolence, next-day sedation, dizziness, impaired psychomotor performance). Neither agent is a prodrug here.
- Onset: unspecified
- Evidence: theoretical
- Severity: moderate
Management: Monitor for enhanced sedative effects. The lemborexant dose may be individualized by the prescriber; counsel on next-day impairment and avoiding driving until effects are known.
What happens
Increased oral sensitive CYP3A4 substrate exposure and an increased risk on severity and frequency of sensitive CYP3A4 substrate-related adverse reactions
Interaction Deep Dive
In the gut, xanomeline produces a temporary, local inhibition of CYP3A4, though this effect does not occur systemically. When xanomeline is taken alongside oral medications that are sensitive CYP3A4 substrates, exposure to those oral sensitive CYP3A4 substrates may rise. As a result, adverse reactions linked to these substrates could occur more frequently and/or with greater severity. In cases of concurrent use, patients should be monitored for any increase in the frequency and/or severity of adverse reactions associated with oral drugs that are sensitive substrates of CYP3A41.
Why it happens (mechanism)
Inhibition of CYP3A4-substrate metabolism by xanomeline
How to manage this interaction
Here is how a care team typically handles this combination:
- Keep taking both medicines as prescribed unless your prescriber tells you otherwise.
- Your team may monitor you more closely for stronger lemborexant effects, such as extra drowsiness, morning grogginess, or dizziness.
- If needed, your lemborexant dose may be adjusted and individualized by your care team.
Tell your pharmacist or doctor if you notice more sleepiness than usual, trouble waking up, or next-day fogginess. Be cautious with driving or activities that need alertness until you know how you respond.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Trospium / Xanomeline and Lemborexant together?
Xanomeline (in Cobenfy) may raise lemborexant levels and increase drowsiness or next-day grogginess, though this is only a theoretical concern. Keep taking both as prescribed and tell your care team if you feel extra sedated. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Trospium / Xanomeline and Lemborexant interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Trospium / Xanomeline and Lemborexant interaction managed?
Here is how a care team typically handles this combination: Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Your team may monitor you more closely for stronger lemborexant effects, such as extra drowsiness, morning grogginess, or dizziness. If needed, your lemborexant dose may be adjusted and individualized by your care team. Tell your pharmacist or doctor if y… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Trospium / Xanomeline or Lemborexant need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
References (1)
- Citation #1
Keep reading about Lemborexant
Keep reading about Trospium / Xanomeline
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist